Advances and Personalized Approaches in the Frontline Treatment of T-Cell Lymphomas
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm12020267
Abstract: Peripheral T-cell lymphomas (PTCLs) are a rare and heterogenous subset of non-Hodgkin lymphoma characterized by an aggressive clinical course. Historically, the treatment of PTCLs have been analogous to that of aggressive B-cell lymphomas; however, it… read more here.
Keywords: personalized approaches; frontline treatment; cell lymphomas; advances personalized ... See more keywords
Advances in personalized neoantigen vaccines for cancer immunotherapy.
Sign Up to like & getrecommendations! Published in 2020 at "Bioscience trends"
DOI: 10.5582/bst.2020.03267
Abstract: Immunotherapy, which targets T cell inhibitory receptors (immune checkpoints), is now being widely used to treat a variety of types of cancer combined with surgery, chemotherapy, or radiotherapy. However, immune checkpoint inhibitors are highly dependent… read more here.
Keywords: advances personalized; vaccines cancer; neoantigen vaccines; personalized neoantigen ... See more keywords